Loading...
Japanese Trademark — JPO
The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark.
Application 2024355582 · 00
Quick Facts
| Application Number | 2024355582 |
| Registration Number | 1790851 |
| Status | 00 |
| Mark (native) | The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark. |
| Mark Type | madrid |
| Owner | Sarepta Therapeutics, Inc. |
| Filed | 2024-05-23 |
| Registered | 2024-01-23 |
Is this trademark active?
The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark. has a current status of 00.
Goods & Services
The specification below is taken directly from the filed record at the Japan Patent Office for each Nice class this trademark covers.
Class 5 — Pharmaceuticals
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases.
Class 41 — Education & Entertainment
Medical training and teaching.
Class 44 — Medical & Beauty Services
Medical services; providing health information.
Applicant
| Name (romanised) | Sarepta Therapeutics, Inc. |
Timeline
- Filed: 2024-05-23
- Registered: 2024-01-23
About This Trademark
'The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark.' is a 00 trademark on the Japan Patent Office register, owned by Sarepta Therapeutics, Inc.. The application (2024355582) was filed on 23 May 2024 and registered on 23 January 2024.
This mark is recorded under multiple classes: Class 5 (pharmaceuticals & medical preparations); Class 41 (education, entertainment & sporting services); Class 44 (medical, veterinary & beauty services), specifically covering: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases.; Medical training and teaching.; Medical services; providing health information.
Frequently Asked Questions
Who owns Japanese trademark 2024355582 ('The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark.')?
Japanese trademark 2024355582 for the mark 'The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark.' in Class 5, 41, 44 is recorded on the Japan Patent Office register as owned by Sarepta Therapeutics, Inc.. This covers one specific Japanese trademark record only — the same brand name may be owned by different parties in other classes, other countries, or as separate registrations.
Is Japanese trademark 2024355582 currently a registered trademark?
No — the Japan Patent Office records the status of Japanese trademark 2024355582 for the mark 'The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark.' as 00.
Which Nice classes is Japanese trademark 2024355582 registered under?
Japanese trademark 2024355582 for the mark 'The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark.' is recorded in Class 5 (pharmaceuticals & medical preparations); Class 41 (education, entertainment & sporting services); Class 44 (medical, veterinary & beauty services). The filed specification reads: Class 5: Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases…
When was Japanese trademark 2024355582 filed?
Japanese trademark 2024355582 for the mark 'The mark consists of two stylized open-shaped polygons, slightly juxtaposed and facing one another that together form a stylized hexagon; the polygon on the left faces to the upper right and consists of five segments and the polygon on the right faces to the lower left and consists of four segment. The word MYOPEPDYS is to the right of the polygons and the term '(vesleteplirsen) injection' is below MYOPEPDYS. Color is not claimed as a feature of the mark.' was filed at the Japan Patent Office on 23 May 2024 and registered on 23 January 2024.
Data Source
Japan (Japan Patent Office)
Japanese trademark data is supplied by the Japan Patent Office (JPO) via the JPO open bulk data release. Official government publications in Japan are not subject to copyright under Article 13 of the Japanese Copyright Act. Local copy last synchronised on 2026-04-25.
The “About This Trademark” summary and FAQ above are AI-generated from the register data shown on this page. They are factual summaries only — always verify details against the official register before making legal decisions.